Global Artificial Intelligence in Healthcare 麻豆原创 Research Report 2023

Publication ID:

PB504236736

Publication Date:

April 5, 2023

Pages:

110

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Artificial Intelligence in Healthcare market was valued at US$ 3982.3 million in 2022 and is anticipated to reach US$ 31960 million by 2029, witnessing a CAGR of 41.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Artificial Intelligence in Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Artificial Intelligence in Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Artificial Intelligence in Healthcare in Patient Data and Risk Analysis is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Artificial Intelligence in Healthcare include Intel Corporation, Nvidia Corporation, Google, IBM Corporation, Microsoft Corporation, General Vision, Enlitic, Next IT and Welltok, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence in Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence in Healthcare.
The Artificial Intelligence in Healthcare market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Artificial Intelligence in Healthcare market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence in Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Intel Corporation
Nvidia Corporation
Google
IBM Corporation
Microsoft Corporation
General Vision
Enlitic
Next IT
Welltok
Icarbonx
Recursion Pharmaceuticals
Koninklijke Philips
General Electric (GE) Company
Siemens Healthineers
Johnson & Johnson Services
Medtronic
Stryker Corporation
Careskore
Zephyr Health
Oncora Medical
Sentrian
Bay Labs
Atomwise
Deep Genomics
Cloudmedx
Segment by Type
Deep Learning
Querying Method
Natural Language Processing
Segment by Application
Patient Data and Risk Analysis
Lifestyle Management and Monitoring
Precision Medicine
In-Patient Care and Hospital Management
Medical Imaging and Diagnosis
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence in Healthcare companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Artificial Intelligence in Healthcare 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Deep Learning
1.2.3 Querying Method
1.2.4 Natural Language Processing
1.3 麻豆原创 by Application
1.3.1 Global Artificial Intelligence in Healthcare 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Patient Data and Risk Analysis
1.3.3 Lifestyle Management and Monitoring
1.3.4 Precision Medicine
1.3.5 In-Patient Care and Hospital Management
1.3.6 Medical Imaging and Diagnosis
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence in Healthcare 麻豆原创 Perspective (2018-2029)
2.2 Artificial Intelligence in Healthcare Growth Trends by Region
2.2.1 Global Artificial Intelligence in Healthcare 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Intelligence in Healthcare Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Artificial Intelligence in Healthcare Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Artificial Intelligence in Healthcare 麻豆原创 Dynamics
2.3.1 Artificial Intelligence in Healthcare Industry Trends
2.3.2 Artificial Intelligence in Healthcare 麻豆原创 Drivers
2.3.3 Artificial Intelligence in Healthcare 麻豆原创 Challenges
2.3.4 Artificial Intelligence in Healthcare 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence in Healthcare Players by Revenue
3.1.1 Global Top Artificial Intelligence in Healthcare Players by Revenue (2018-2023)
3.1.2 Global Artificial Intelligence in Healthcare Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Artificial Intelligence in Healthcare 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence in Healthcare Revenue
3.4 Global Artificial Intelligence in Healthcare 麻豆原创 Concentration Ratio
3.4.1 Global Artificial Intelligence in Healthcare 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Healthcare Revenue in 2022
3.5 Artificial Intelligence in Healthcare Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence in Healthcare Product Solution and Service
3.7 Date of Enter into Artificial Intelligence in Healthcare 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence in Healthcare Breakdown Data by Type
4.1 Global Artificial Intelligence in Healthcare Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Artificial Intelligence in Healthcare Forecasted 麻豆原创 Size by Type (2024-2029)
5 Artificial Intelligence in Healthcare Breakdown Data by Application
5.1 Global Artificial Intelligence in Healthcare Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Artificial Intelligence in Healthcare Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Artificial Intelligence in Healthcare 麻豆原创 Size (2018-2029)
6.2 North America Artificial Intelligence in Healthcare 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Intelligence in Healthcare 麻豆原创 Size by Country (2018-2023)
6.4 North America Artificial Intelligence in Healthcare 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence in Healthcare 麻豆原创 Size (2018-2029)
7.2 Europe Artificial Intelligence in Healthcare 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Intelligence in Healthcare 麻豆原创 Size by Country (2018-2023)
7.4 Europe Artificial Intelligence in Healthcare 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence in Healthcare 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Artificial Intelligence in Healthcare 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Intelligence in Healthcare 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Intelligence in Healthcare 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence in Healthcare 麻豆原创 Size (2018-2029)
9.2 Latin America Artificial Intelligence in Healthcare 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Intelligence in Healthcare 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Artificial Intelligence in Healthcare 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence in Healthcare 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Artificial Intelligence in Healthcare 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Intelligence in Healthcare 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Intelligence in Healthcare 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Intel Corporation
11.1.1 Intel Corporation Company Detail
11.1.2 Intel Corporation Business Overview
11.1.3 Intel Corporation Artificial Intelligence in Healthcare Introduction
11.1.4 Intel Corporation Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.1.5 Intel Corporation Recent Development
11.2 Nvidia Corporation
11.2.1 Nvidia Corporation Company Detail
11.2.2 Nvidia Corporation Business Overview
11.2.3 Nvidia Corporation Artificial Intelligence in Healthcare Introduction
11.2.4 Nvidia Corporation Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.2.5 Nvidia Corporation Recent Development
11.3 Google
11.3.1 Google Company Detail
11.3.2 Google Business Overview
11.3.3 Google Artificial Intelligence in Healthcare Introduction
11.3.4 Google Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.3.5 Google Recent Development
11.4 IBM Corporation
11.4.1 IBM Corporation Company Detail
11.4.2 IBM Corporation Business Overview
11.4.3 IBM Corporation Artificial Intelligence in Healthcare Introduction
11.4.4 IBM Corporation Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.4.5 IBM Corporation Recent Development
11.5 Microsoft Corporation
11.5.1 Microsoft Corporation Company Detail
11.5.2 Microsoft Corporation Business Overview
11.5.3 Microsoft Corporation Artificial Intelligence in Healthcare Introduction
11.5.4 Microsoft Corporation Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.5.5 Microsoft Corporation Recent Development
11.6 General Vision
11.6.1 General Vision Company Detail
11.6.2 General Vision Business Overview
11.6.3 General Vision Artificial Intelligence in Healthcare Introduction
11.6.4 General Vision Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.6.5 General Vision Recent Development
11.7 Enlitic
11.7.1 Enlitic Company Detail
11.7.2 Enlitic Business Overview
11.7.3 Enlitic Artificial Intelligence in Healthcare Introduction
11.7.4 Enlitic Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.7.5 Enlitic Recent Development
11.8 Next IT
11.8.1 Next IT Company Detail
11.8.2 Next IT Business Overview
11.8.3 Next IT Artificial Intelligence in Healthcare Introduction
11.8.4 Next IT Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.8.5 Next IT Recent Development
11.9 Welltok
11.9.1 Welltok Company Detail
11.9.2 Welltok Business Overview
11.9.3 Welltok Artificial Intelligence in Healthcare Introduction
11.9.4 Welltok Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.9.5 Welltok Recent Development
11.10 Icarbonx
11.10.1 Icarbonx Company Detail
11.10.2 Icarbonx Business Overview
11.10.3 Icarbonx Artificial Intelligence in Healthcare Introduction
11.10.4 Icarbonx Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.10.5 Icarbonx Recent Development
11.11 Recursion Pharmaceuticals
11.11.1 Recursion Pharmaceuticals Company Detail
11.11.2 Recursion Pharmaceuticals Business Overview
11.11.3 Recursion Pharmaceuticals Artificial Intelligence in Healthcare Introduction
11.11.4 Recursion Pharmaceuticals Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.11.5 Recursion Pharmaceuticals Recent Development
11.12 Koninklijke Philips
11.12.1 Koninklijke Philips Company Detail
11.12.2 Koninklijke Philips Business Overview
11.12.3 Koninklijke Philips Artificial Intelligence in Healthcare Introduction
11.12.4 Koninklijke Philips Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.12.5 Koninklijke Philips Recent Development
11.13 General Electric (GE) Company
11.13.1 General Electric (GE) Company Company Detail
11.13.2 General Electric (GE) Company Business Overview
11.13.3 General Electric (GE) Company Artificial Intelligence in Healthcare Introduction
11.13.4 General Electric (GE) Company Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.13.5 General Electric (GE) Company Recent Development
11.14 Siemens Healthineers
11.14.1 Siemens Healthineers Company Detail
11.14.2 Siemens Healthineers Business Overview
11.14.3 Siemens Healthineers Artificial Intelligence in Healthcare Introduction
11.14.4 Siemens Healthineers Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.14.5 Siemens Healthineers Recent Development
11.15 Johnson & Johnson Services
11.15.1 Johnson & Johnson Services Company Detail
11.15.2 Johnson & Johnson Services Business Overview
11.15.3 Johnson & Johnson Services Artificial Intelligence in Healthcare Introduction
11.15.4 Johnson & Johnson Services Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.15.5 Johnson & Johnson Services Recent Development
11.16 Medtronic
11.16.1 Medtronic Company Detail
11.16.2 Medtronic Business Overview
11.16.3 Medtronic Artificial Intelligence in Healthcare Introduction
11.16.4 Medtronic Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.16.5 Medtronic Recent Development
11.17 Stryker Corporation
11.17.1 Stryker Corporation Company Detail
11.17.2 Stryker Corporation Business Overview
11.17.3 Stryker Corporation Artificial Intelligence in Healthcare Introduction
11.17.4 Stryker Corporation Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.17.5 Stryker Corporation Recent Development
11.18 Careskore
11.18.1 Careskore Company Detail
11.18.2 Careskore Business Overview
11.18.3 Careskore Artificial Intelligence in Healthcare Introduction
11.18.4 Careskore Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.18.5 Careskore Recent Development
11.19 Zephyr Health
11.19.1 Zephyr Health Company Detail
11.19.2 Zephyr Health Business Overview
11.19.3 Zephyr Health Artificial Intelligence in Healthcare Introduction
11.19.4 Zephyr Health Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.19.5 Zephyr Health Recent Development
11.20 Oncora Medical
11.20.1 Oncora Medical Company Detail
11.20.2 Oncora Medical Business Overview
11.20.3 Oncora Medical Artificial Intelligence in Healthcare Introduction
11.20.4 Oncora Medical Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.20.5 Oncora Medical Recent Development
11.21 Sentrian
11.21.1 Sentrian Company Detail
11.21.2 Sentrian Business Overview
11.21.3 Sentrian Artificial Intelligence in Healthcare Introduction
11.21.4 Sentrian Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.21.5 Sentrian Recent Development
11.22 Bay Labs
11.22.1 Bay Labs Company Detail
11.22.2 Bay Labs Business Overview
11.22.3 Bay Labs Artificial Intelligence in Healthcare Introduction
11.22.4 Bay Labs Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.22.5 Bay Labs Recent Development
11.23 Atomwise
11.23.1 Atomwise Company Detail
11.23.2 Atomwise Business Overview
11.23.3 Atomwise Artificial Intelligence in Healthcare Introduction
11.23.4 Atomwise Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.23.5 Atomwise Recent Development
11.24 Deep Genomics
11.24.1 Deep Genomics Company Detail
11.24.2 Deep Genomics Business Overview
11.24.3 Deep Genomics Artificial Intelligence in Healthcare Introduction
11.24.4 Deep Genomics Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.24.5 Deep Genomics Recent Development
11.25 Cloudmedx
11.25.1 Cloudmedx Company Detail
11.25.2 Cloudmedx Business Overview
11.25.3 Cloudmedx Artificial Intelligence in Healthcare Introduction
11.25.4 Cloudmedx Revenue in Artificial Intelligence in Healthcare Business (2018-2023)
11.25.5 Cloudmedx Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Intel Corporation
Nvidia Corporation
Google
IBM Corporation
Microsoft Corporation
General Vision
Enlitic
Next IT
Welltok
Icarbonx
Recursion Pharmaceuticals
Koninklijke Philips
General Electric (GE) Company
Siemens Healthineers
Johnson & Johnson Services
Medtronic
Stryker Corporation
Careskore
Zephyr Health
Oncora Medical
Sentrian
Bay Labs
Atomwise
Deep Genomics
Cloudmedx

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.